Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
Neuropsychology
|
September 22, 2022
Regression-based cognitive change norms applied in biochemically defined predementia Alzheimer's disease
Ingvild Vøllo Eliassen, Bjørn-Eivind Kirsebom, Tormod Fladby, et al.
Applied Neuropsychology. Adult
|
June 18, 2025
Pathological biomarkers for Alzheimer's disease in cognitively unimpaired individuals are not associated with cognitive decline at two-year follow-up
Ingvild Vøllo Eliassen, Bjørn-Eivind Kirsebom, Knut Waterloo, et al.
Neurobiology of Aging
|
June 5, 2024
Age-adjusted CSF t-tau and NfL do not improve diagnostic accuracy for prodromal Alzheimer's disease
Stephanie Lindgård Knudtzon, Kaja Nordengen, Gøril Rolfseng Grøntvedt, et al.
The Clinical Neuropsychologist
|
August 15, 2022
Regression-based normative data for the Rey Auditory Verbal Learning Test in Norwegian and Swedish adults aged 49-79 and comparison with published norms
Jacob Espenes, Ingvild Vøllo Eliassen, Fredrik Öhman, et al.
Brain Communications
|
October 20, 2022
Stable cerebrospinal fluid neurogranin and β-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer's disease patients
Bjørn Eivind Kirsebom, Grit Richter, Kaja Nordengen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 10, 2026
Genotype-phenotype interaction in Alzheimer's disease immune activation
Stephanie Knudtzon, Bjørn-Eivind Kirsebom, Lene Pålhaugen, et al.
Neurology
|
May 15, 2025
Associations Between Changes in Levels of Phosphorylated Tau and Severity of Cognitive Impairment in Early Alzheimer Disease
Fernando Gonzalez-Ortiz, Bjørn-Eivind Kirsebom, Yara Yakoub, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 29, 2025
Repeated plasma p-tau217 measurements to monitor clinical progression heterogeneity
Bjørn-Eivind Kirsebom, Fernando Gonzalez-Ortiz, Sinthujah Vigneswaran, et al.
Molecular Neurodegeneration
|
October 14, 2025
Cerebrospinal fluid markers link to synaptic plasticity responses and Alzheimer's disease genetic pathways
Bjørn-Eivind Kirsebom, Johanna Nilsson, Ellen Vromen, et al.
Journal of Neuroinflammation
|
December 14, 2023
Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer's disease
Kaja Nordengen, Bjørn-Eivind Kirsebom, Grit Richter, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
Neuropsychology
|
September 22, 2022
Regression-based cognitive change norms applied in biochemically defined predementia Alzheimer's disease
Ingvild Vøllo Eliassen, Bjørn-Eivind Kirsebom, Tormod Fladby, et al.
Applied Neuropsychology. Adult
|
June 18, 2025
Pathological biomarkers for Alzheimer's disease in cognitively unimpaired individuals are not associated with cognitive decline at two-year follow-up
Ingvild Vøllo Eliassen, Bjørn-Eivind Kirsebom, Knut Waterloo, et al.
Neurobiology of Aging
|
June 5, 2024
Age-adjusted CSF t-tau and NfL do not improve diagnostic accuracy for prodromal Alzheimer's disease
Stephanie Lindgård Knudtzon, Kaja Nordengen, Gøril Rolfseng Grøntvedt, et al.
The Clinical Neuropsychologist
|
August 15, 2022
Regression-based normative data for the Rey Auditory Verbal Learning Test in Norwegian and Swedish adults aged 49-79 and comparison with published norms
Jacob Espenes, Ingvild Vøllo Eliassen, Fredrik Öhman, et al.
Brain Communications
|
October 20, 2022
Stable cerebrospinal fluid neurogranin and β-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer's disease patients
Bjørn Eivind Kirsebom, Grit Richter, Kaja Nordengen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 10, 2026
Genotype-phenotype interaction in Alzheimer's disease immune activation
Stephanie Knudtzon, Bjørn-Eivind Kirsebom, Lene Pålhaugen, et al.
Neurology
|
May 15, 2025
Associations Between Changes in Levels of Phosphorylated Tau and Severity of Cognitive Impairment in Early Alzheimer Disease
Fernando Gonzalez-Ortiz, Bjørn-Eivind Kirsebom, Yara Yakoub, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 29, 2025
Repeated plasma p-tau217 measurements to monitor clinical progression heterogeneity
Bjørn-Eivind Kirsebom, Fernando Gonzalez-Ortiz, Sinthujah Vigneswaran, et al.
Molecular Neurodegeneration
|
October 14, 2025
Cerebrospinal fluid markers link to synaptic plasticity responses and Alzheimer's disease genetic pathways
Bjørn-Eivind Kirsebom, Johanna Nilsson, Ellen Vromen, et al.
Journal of Neuroinflammation
|
December 14, 2023
Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer's disease
Kaja Nordengen, Bjørn-Eivind Kirsebom, Grit Richter, et al.
Page
of 9